000 01341 a2200373 4500
005 20250517113337.0
264 0 _c20170102
008 201701s 0 0 eng d
022 _a1179-1918
024 7 _a10.1007/s40261-016-0444-5
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aYan, Xiaoyu
245 0 0 _aCost Effectiveness of Apixaban and Enoxaparin for the Prevention of Venous Thromboembolism After Total Knee Replacement in China.
_h[electronic resource]
260 _bClinical drug investigation
_cDec 2016
300 _a1001-1010 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article
650 0 4 _aAnticoagulants
_xtherapeutic use
650 0 4 _aArthroplasty, Replacement, Knee
_xmethods
650 0 4 _aChina
650 0 4 _aCost-Benefit Analysis
650 0 4 _aDecision Trees
650 0 4 _aEnoxaparin
_xeconomics
650 0 4 _aHumans
650 0 4 _aPyrazoles
_xeconomics
650 0 4 _aPyridones
_xeconomics
650 0 4 _aQuality-Adjusted Life Years
650 0 4 _aVenous Thromboembolism
_xprevention & control
700 1 _aGu, Xiaohua
700 1 _aZhou, Lei
700 1 _aLin, Houweng
700 1 _aWu, Bin
773 0 _tClinical drug investigation
_gvol. 36
_gno. 12
_gp. 1001-1010
856 4 0 _uhttps://doi.org/10.1007/s40261-016-0444-5
_zAvailable from publisher's website
999 _c26378270
_d26378270